Biotechnology Value Trading Fund OS LP's Net Worth
$0
Who is Biotechnology Value Trading Fund OS LP?
Biotechnology Value Trading Fund OS LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Allakos Inc., Rain Therapeutics Inc., IMMUNE DESIGN CORP., Oncothyreon Inc., XOMA Corp, Xenon Pharmaceuticals Inc., Cullinan Oncology, Inc., Merus N.V., Nivalis Therapeutics, Inc., Repare Therapeutics Inc., PIERIS PHARMACEUTICALS, INC., Verastem, Inc., Syndax Pharmaceuticals Inc, CTI BIOPHARMA CORP, IDEAYA Biosciences, Inc., CYTOKINETICS INC, Kymera Therapeutics, Inc., Calithera Biosciences, Inc., CONCERT PHARMACEUTICALS, INC., CytomX Therapeutics, Inc., MoonLake Immunotherapeutics, GLYCOMIMETICS INC, Principia Biopharma Inc., INFINITY PHARMACEUTICALS, INC., Eledon Pharmaceuticals, Inc., Olema Pharmaceuticals, Inc., Regulus Therapeutics Inc., ESSA Pharma Inc., 4D Molecular Therapeutics, Inc., Third Harmonic Bio, Inc., FIVE PRIME THERAPEUTICS, INC., Structure Therapeutics Inc., ARQULE INC, enGene Holdings Inc., and POINT Biopharma Global Inc..
SEC CIK
Biotechnology Value Trading Fund OS LP's CIK is 0001660683
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Allakos Inc. (ALLK) Snapshot price: $0.648
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rain Oncology Inc. (RAIN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -8.58M |
—
|
—
|
0
|
Jan 25 - Jan 26
| |||
Form 4
| +47.80% | 1.71M |
$5.83 | $9,971,387.14 | 5.29M |
Nov 8
| |||
Form 4
| +20.43% | 557.73K |
$12.00 | $6,692,637.85 | 3.29M |
Jan 6 - Jan 7
| |||
Form 4
| +0.41% | 11.03K |
$13.94 | $153,828.71 | 2.73M |
Sep 21
| |||
Form 4
| +16.86% | 392.27K |
$16.49 | $6,468,515.81 | 2.72M |
Sep 13
| |||
Form 4
| +33.73% | 587K |
$15.47 | $9,078,692.10 | 2.33M |
Jul 1 - Jul 6
| |||
Form 4
| +7.63% | 123.35K |
$15.94 | $1,966,334.17 | 1.74M |
May 21 - May 24
| |||
Form 4
| +14.80% | 208.47K |
$16.59 | $3,457,720.14 | 1.62M |
May 18 - May 19
| |||
Form 4
| +4.30% | 58K |
$14.26 | $827,167.00 | 1.41M |
May 13
| |||
Form 4/A
| +522.18% | 1.13M |
$16.86 | $19,103,379.78 | 1.35M |
Apr 23 - Apr 26
| |||
Form 4
|
∞
| 4.93M |
$16.86 |
—
| 4.93M |
Apr 23 - Apr 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMMUNE DESIGN CORP. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.77% | -902.00K |
$1.83 | -$1,653,907.20 | 4.82M |
Dec 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cascadian Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
XOMA Corp (XOMA) Snapshot price: $28.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
| +0.66% | 22.25K |
$19.15 | $420,737.35 | 3.41M |
Jan 5 - Jan 6
| |||
Form 4
| +0.73% | 24.64K |
$16.61 | $409,309.13 | 3.39M |
Sep 23 - Sep 27
| |||
Form 4
| +1.70% | 56.31K |
$17.70 | $990,718.12 | 3.36M |
Sep 14 - Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| -15.58% | -651.70K |
$38.36 | -$24,999,212.00 | 3.53M |
Mar 31
| |||
Form 4
|
∞
| 200K |
$25.00 | $5,000,000.00 | 200K |
Dec 11
| |||
Form 4
| +1.37% | 51.37K |
$18.34 | $941,963.46 | 3.79M |
Sep 21 - Sep 23
| |||
Form 4
| +0.21% | 7.74K |
$18.77 | $145,228.13 | 3.74M |
Sep 4
| |||
Form 4
| +0.96% | 35.62K |
$18.71 | $666,484.48 | 3.73M |
Aug 28 - Sep 1
| |||
Form 4
| +0.77% | 28.18K |
$19.41 | $546,650.26 | 3.7M |
Aug 21 - Aug 25
| |||
Form 4
| +0.31% | 6.16K |
$19.47 | $120,003.55 | 1.97M |
Aug 18 - Aug 20
| |||
Form 4
| +1.40% | 27.02K |
$18.46 | $498,736.30 | 1.96M |
Aug 12 - Aug 14
| |||
Form 4
| +52.59% | 1.25M |
$13.00 | $16,286,036.00 | 3.63M |
Apr 15
| |||
Form 4
| +0.65% | 8.26K |
$17.20 | $142,129.23 | 1.28M |
Mar 25
| |||
Form 4
| +0.35% | 4.44K |
$14.52 | $64,474.70 | 1.27M |
Mar 18
| |||
Form 4
| +10.31% | 118.28K |
$17.94 | $2,121,653.82 | 1.27M |
Mar 13 - Mar 17
| |||
Form 4
| +24.56% | 845.46K |
$22.00 | $18,600,186.00 | 4.29M |
Dec 18 - Dec 19
| |||
Form 4
| +3.88% | 27.91K |
$14.63 | $408,227.87 | 746.45K |
May 10 - May 14
| |||
Form 4
| +3.60% | 25K |
$14.19 | $354,792.50 | 718.54K |
Dec 14 - Dec 18
| |||
Form 4
| +5.55% | 36.46K |
$14.46 | $527,241.95 | 693.54K |
Dec 11 - Dec 13
| |||
Form 4
| +10.24% | 61.02K |
$14.71 | $897,447.93 | 657.08K |
Dec 6 - Dec 10
| |||
Form 4
| +1.67% | 9.8K |
$14.91 | $146,139.15 | 596.05K |
Nov 30 - Dec 4
| |||
Form 4
| +5.34% | 29.7K |
$15.10 | $448,484.00 | 586.25K |
Nov 27 - Nov 29
| |||
Form 4
| +14.92% | 72.25K |
$14.17 | $1,023,657.89 | 556.55K |
Nov 19 - Nov 21
| |||
Form 4
| +7.07% | 31.99K |
$13.48 | $431,347.68 | 484.3K |
Nov 15 - Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||